Form 483

Ecometics, Inc. Form 483, 2018-09-07

FDA issued a Form 483 to Ecometics, Inc. on 2018-09-07 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Ecometics, Inc. · Norwalk, United States · Issued September 7, 2018

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Sep 2018
21 CFR 211.137(a)

Expiration date lacking

Cited by Helen B Ricalde

7 Sep 2018
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Helen B Ricalde

7 Sep 2018
21 CFR 211.165(b)

Microbiological testing

Cited by Helen B Ricalde

7 Sep 2018
21 CFR 211.165(e)

Test methods

Cited by Helen B Ricalde

7 Sep 2018
21 CFR 211.166(a)

Written program not followed

Cited by Helen B Ricalde

Inspected site

EIEcometics, Inc.Norwalk, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.137(a)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.65(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 9 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere